Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt.biotech. Regulatory News (IBT)

Share Price Information for Int.biotech. (IBT)

Share Price is delayed by 15 minutes
Get Live Data
990.00    24.00 (2.48%)
Bid:
984.00
Ask:
994.00
Spread: 10.00 (1.016%)
Market Cap: £315.10m
IBT Live PriceLast checked at - London Stock Exchange

Intraday Int.biotech. Share Chart

Total Voting Rights

31 Jan 2025 16:57

RNS Number : 5336V
Intl. Biotechnology Trust PLC
31 January 2025
 

Voting rights and capital

International Biotechnology Trust plc (the "Company") announces that as at Friday 31 January 2025 its issued share capital consists of 41,383,817 ordinary shares of 25p each, the total number of shares in treasury is 5,593,249 and the total number of voting rights in the Company is 35,790,568.

The above figure of 35,790,568 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Enquiries:

Schroder Investment Management Limited

Tel: 020 7658 6000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVREAKFFDSXSEFA
Date   Source Headline
14th Apr 202611:41 amRNSNet Asset Value(s)
13th Apr 202611:51 amRNSNet Asset Value(s)
10th Apr 20264:40 pmRNSCompliance with Market Abuse Regulation
10th Apr 202612:06 pmRNSNet Asset Value(s)
9th Apr 202611:32 amRNSNet Asset Value(s)
8th Apr 202611:50 amRNSNet Asset Value(s)
7th Apr 20265:15 pmRNSTransaction in Own Shares
7th Apr 202611:56 amRNSNet Asset Value(s)
7th Apr 202610:25 amRNS-RPortfolio company Soleno acquired by Neurocrine
1st Apr 20265:24 pmRNSTransaction in Own Shares
1st Apr 202612:02 pmRNSNet Asset Value(s)
31st Mar 20262:55 pmRNS-RIBT portfolio company Apellis acquired by Biogen
31st Mar 202612:00 pmRNSNet Asset Value(s)
30th Mar 202611:46 amRNSNet Asset Value(s)
27th Mar 202611:51 amRNSNet Asset Value(s)
26th Mar 202611:56 amRNSNet Asset Value(s)
25th Mar 20262:43 pmRNS-RIBT portfolio company Terns acquired by Merck
25th Mar 202612:01 pmRNSNet Asset Value(s)
24th Mar 202611:54 amRNSNet Asset Value(s)
23rd Mar 202611:56 amRNSNet Asset Value(s)
20th Mar 202611:54 amRNSNet Asset Value(s)
19th Mar 202611:54 amRNSNet Asset Value(s)
18th Mar 202611:45 amRNSNet Asset Value(s)
17th Mar 202611:28 amRNSNet Asset Value(s)
16th Mar 202611:52 amRNSNet Asset Value(s)
13th Mar 202611:52 amRNSNet Asset Value(s)
12th Mar 20267:00 amRNS-RKepler Trust Intelligence: New Research
11th Mar 202611:56 amRNSNet Asset Value(s)
9th Mar 202611:48 amRNSNet Asset Value(s)
9th Mar 20268:42 amRNS-RPortfolio company Day One acquired by Servier
6th Mar 202611:42 amRNSNet Asset Value(s)
5th Mar 202612:02 pmRNSNet Asset Value(s)
4th Mar 202611:49 amRNSNet Asset Value(s)
3rd Mar 202611:35 amRNSNet Asset Value(s)
2nd Mar 202612:24 pmRNSNet Asset Value(s)
27th Feb 202611:14 amRNSNet Asset Value(s)
26th Feb 202611:49 amRNSNet Asset Value(s)
25th Feb 202611:54 amRNSNet Asset Value(s)
24th Feb 202611:43 amRNSNet Asset Value(s)
23rd Feb 202611:40 amRNSNet Asset Value(s)
20th Feb 202610:53 amRNSNet Asset Value(s)
19th Feb 202611:36 amRNSNet Asset Value(s)
18th Feb 202611:47 amRNSNet Asset Value(s)
17th Feb 202611:32 amRNSNet Asset Value(s)
16th Feb 202611:56 amRNSNet Asset Value(s)
13th Feb 202611:52 amRNSNet Asset Value(s)
12th Feb 202611:04 amRNSNet Asset Value(s)
11th Feb 202611:24 amRNSNet Asset Value(s)
10th Feb 202612:02 pmRNSRestatement of Net Asset Value(s)
10th Feb 202611:41 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.